Novo Nordisk are a global healthcare company, founded in
Denmark in 1923.
Our purpose at Novo Nordisk UK is to defeat diabetes,
obesity, rare blood and hormone disorders, to improve the lives of
millions of people in the UK. Today, we supply over half the world’s insulin.
Everything we do is based on acting socially, environmentally and
financially responsibly with planned zero environmental impact. We
call this “Circular for Zero”. We are proud to be working
together with a range of organisations providing services in the UK
healthcare sector to bring PenCycle to life.